Key differential aspects of the group of glucagon-like peptide-1 receptor agonist drugs There are several arGLP-1 s approved or under study for the use in DM2: exenatide (exenatide and exenatide LAR or weekly), liraglutide, lixisenatide, dulaglutide, semaglutide, albiglutide (withdrawn from the market), and efpeglenatide (in clinical development)
Signs of dehydration, ongoing vomiting, or abdominal pain are important reasons to immediately call a doctor when on GLP-1
How should the BPC-157 spray be stored
The studies have not been scrutinized by outside experts or published in medical journals, so the data is considered preliminary
"The 503A pathway is the first step of accountability, and I think that's really ultimately what we're looking for